Veterinary Medicines

Rispoval Lactovac C vakcina A.U.V.

Not authorised
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
Download as PDF

Product identification

Medicine name:
Rispoval Lactovac C vakcina A.U.V.
Active substance:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Bovine rotavirus A, strain Holland, Inactivated
  • Bovine rotavirus A, strain 1005/78, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
    250.00
    haemagglutinating units
    /
    1.00
    unit(s)/dose
  • Bovine coronavirus, strain 800, Inactivated
    5.80
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Bovine rotavirus A, strain Holland, Inactivated
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
  • Bovine rotavirus A, strain 1005/78, Inactivated
    7.40
    log10 50% tissue culture infectious dose
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: